Avadel Pharmaceuticals Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Laidlaw Downgrades Avadel Pharmaceuticals (AVDL) to Neutral
November 6, 2018 8:58 AM ESTLaidlaw analyst Francois Brisebois downgraded Avadel Pharmaceuticals (NASDAQ: AVDL) from Buy to Neutral with a price target of $5.50 (from $11.00).
For an analyst ratings summary and ratings history on Avadel Pharmaceuticals click here. For more ratings news on Avadel Pharmaceuticals click here.
Shares of Avadel Pharmaceuticals closed at $3.06 yesterday.
... MoreAvadel Pharmaceuticals (AVDL) PT Lowered to $10 at Ladenburg Thalmann
November 6, 2018 6:40 AM ESTLadenburg Thalmann analyst Matthew Kaplan lowered the price target on Avadel Pharmaceuticals (NASDAQ: AVDL) to $10.00 (from $17.50) while maintaining a Buy rating.
... More